Jacobo Mintzer to Risperidone
This is a "connection" page, showing publications Jacobo Mintzer has written about Risperidone.
Connection Strength
1.439
-
Using risperidone for Alzheimer's dementia-associated psychosis. Expert Opin Pharmacother. 2008 Oct; 9(14):2537-43.
Score: 0.306
-
Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial. Am J Geriatr Psychiatry. 2006 Mar; 14(3):280-91.
Score: 0.256
-
A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone. Curr Med Res Opin. 2004 Sep; 20(9):1483-91.
Score: 0.231
-
Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update. Psychopharmacol Bull. 2003; 37(4):116-32.
Score: 0.205
-
Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: The Role of Hallucinations. Am J Psychiatry. 2017 04 01; 174(4):362-369.
Score: 0.134
-
Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med. 2012 Oct 18; 367(16):1497-507.
Score: 0.101
-
The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design. Am J Geriatr Psychiatry. 2012 Apr; 20(4):362-73.
Score: 0.097
-
The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Int J Geriatr Psychiatry. 2007 May; 22(5):475-84.
Score: 0.069
-
Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry. 1999 Feb; 60(2):107-15.
Score: 0.039